Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Biotech Acquisition Company Announces Confidential Submission Of Registration Statement On Form S-4 Related To Proposed Merger With Blade Therapeutics

Author: Benzinga Newsdesk | January 03, 2022 09:01am

 Biotech Acquisition Company (NASDAQ:BIOT) ("BAC"), a publicly traded special purpose acquisition company affiliated with SPRIM Global Investments, today announced that it has made a confidential submission to the United States Securities and Exchange Commission ("SEC"), for receipt by the SEC on December 27, 2021, of a draft registration statement on Form S-4 (the "Registration Statement") relating to its previously announced proposed business combination with Blade Therapeutics, Inc. ("Blade"), a biopharmaceutical company based in South San Francisco, CA. 

Posted In: BIOT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist